Pharmacist Intervention for Glycemic Control in The Community

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

Insulin glargine

10 units at bedtime of insulin glargine will be prescribed to the patients who has HbA1c levels of 7.5-11%. Insulin glargine dose is going to be titrated by increments of 1 unit daily by the patient to achieve a morning fasting glucose of \<=5.5mmol/L

Trial Locations (1)

T6G 2C8

EPICORE Centre, Edmonton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Alberta

OTHER

NCT01335763 - Pharmacist Intervention for Glycemic Control in The Community | Biotech Hunter | Biotech Hunter